{
    "clinical_study": {
        "@rank": "36863", 
        "acronym": "MxT Ag 05", 
        "arm_group": {
            "arm_group_label": "Mepilex Transfer Ag", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "An open, non-comparative, multi-centre post marketing clinical follow-up, PMCF,\n      investigation to evaluate performance and safety on diabetic foot ulcer, dfu, when using\n      mepilex transfer Ag as intended."
        }, 
        "brief_title": "TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetic Foot Ulcers", 
        "condition_browse": {
            "mesh_term": [
                "Ulcer", 
                "Foot Ulcer", 
                "Diabetic Foot"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Both gender>=18 years old\n\n          2. Subjects with type 1 or 2 diabetes mellitus\n\n          3. Two of the signs of infection must be present and recorded (redness, heat, oedema,\n             pain, increased exudates amount, deteriorating wound, fever, odour)\n\n          4. Ulcer localization; below the ankle\n\n          5. Signed Informed Consent\n\n        Exclusion Criteria:\n\n          1. Dry wound\n\n          2. Known allergy/hypersensitivity to the dressing\n\n          3. Treated with other Silver dressing on the ulcer target within 1 week prior to this\n             investigation\n\n          4. Subjects who will have problems following the clinical investigation plan\n\n          5. Subjects enrolled in the investigation already\n\n          6. Subjects included in other ongoing clinical investigation at present or during the\n             past 30 days. Subjects participating in a clinical sample investigation  might be\n             enrolled in the investigation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01964521", 
            "org_study_id": "MxT Ag 05"
        }, 
        "intervention": {
            "arm_group_label": "Mepilex Transfer Ag", 
            "intervention_name": "Mepilex Transfer Ag", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 19, 2014", 
        "location": [
            {
                "contact": {
                    "email": "ketan.dhatariya@nnuh.nhs.uk", 
                    "last_name": "Ketan Dhatariya, doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Norwich", 
                        "country": "United Kingdom", 
                        "state": "Colney Lane", 
                        "zip": "NR4 7UY"
                    }, 
                    "name": "The Norfolk & Norwich University Hospitals NHS foundation"
                }, 
                "investigator": {
                    "last_name": "Ketan Dhatariya, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bernd Franke, Doctor", 
                    "phone": "01709/304157"
                }, 
                "facility": {
                    "address": {
                        "city": "Rotherham", 
                        "country": "United Kingdom", 
                        "zip": "S60 2UD"
                    }, 
                    "name": "The Rotherham NHS Foundation Trust"
                }, 
                "investigator": {
                    "last_name": "Bernd Franke, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended", 
        "overall_contact": {
            "email": "ketan.dhatariya@nnuh.nhs.uk", 
            "last_name": "Ketan Dhatarlya, doctor"
        }, 
        "overall_official": {
            "affiliation": "Norfolk & Norwich University Hospitals NHS foundation", 
            "last_name": "Ketan Dhatariya, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Research Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "changes in signs and symptoms of local infection", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01964521"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "levels of pain in connetion to dressing changes.", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "Molnlycke Health Care AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Molnlycke Health Care AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}